Duration of Follow Up for New Molecular Entities Approved in 2005, 2006, and 2007

Basic Details
Date Posted
Friday, April 16, 2021
Status
Complete
Medical Product
new molecular entities (NMEs)
Description

In this report we described baseline characteristics and the duration of follow-up time among new users of 20 new molecular entities (NMEs) approved in 2005, 22 NMEs approved in 2006, and 17 NMEs approved in 2007 by the U.S. Food and Drug Administration in the Sentinel Distributed Database (SDD).

Additional Details
FDA Center
CDER
Time Period
January 1, 2005 - June 30, 2018; January 1, 2006 - June 30, 2018; January 1, 2007 - June 30, 2018
Study Type
Modular Program
Assessment Type
Exploratory Analyses
Population / Cohort
All individuals
Data Sources
Sentinel Distributed Database (SDD)